Entire cohort (N = 707) | Matched cohort (N = 462) | |||||
---|---|---|---|---|---|---|
NELNs ≤15 (N = 352) | NELNs > 15 (N = 355) | NELNs ≤15 (N = 231) | NELNs > 15 (N = 231) | |||
Variables | P value | P value | ||||
Sex, n (%) | 0.360* | 0.212* | ||||
Male | 251 (71.3%) | 264 (74.4%) | 173 (74.9%) | 161 (69.7%) | ||
Female | 101 (28.7%) | 91 (25.6%) | 58 (25.1%) | 70 (30.3%) | ||
Drinking history, n (%) | 0.001* | 0.761* | ||||
No | 271 (77.0%) | 235 (66.2%) | 163 (70.6%) | 160 (69.3%) | ||
Yes | 81 (23.0%) | 120 (33.8%) | 68 (29.4%) | 71 (30.7%) | ||
Smoking history, n (%) | 0.004* | 0.774* | ||||
No | 152 (43.2%) | 116 (32.7%) | 87 (37.7%) | 90 (39.0%) | ||
Yes | 200 (56.8%) | 239 (67.3%) | 144 (62.3%) | 141 (61.0%) | ||
Tumor differentiation, n (%) | 0.373* | 0.318* | ||||
Well | 84 (23.9%) | 96 (27.0%) | 54 (23.4%) | 60 (26.0%) | ||
Moderate | 192 (54.5%) | 175 (49.3%) | 126 (54.5%) | 110 (47.6%) | ||
Poor | 76 (21.6%) | 84 (23.7%) | 51 (22.1%) | 61 (26.4%) | ||
pT stage, n (%) | 0.033* | 0.955* | ||||
T1 | 60 (17.0%) | 47 (13.2%) | 35 (15.2%) | 37 (16.0%) | ||
T2 | 107 (30.4%) | 87 (24.5%) | 56 (24.2%) | 54 (23.4%) | ||
T3 | 185 (52.6%) | 221 (62.3%) | 140 (60.6%) | 140 (60.6%) | ||
Surgical approaches, n (%) | < 0.001* | 0.095** | ||||
Sweet | 287 (81.5%) | 194 (54.6%) | 178 (77.1%) | 179 (77.5%) | ||
Ivor-Lewis | 15 (4.3%) | 9 (2.5%) | 10 (4.3%) | 9 (3.9%) | ||
McKeown | 37 (10.5%) | 145 (40.8%) | 33 (14.3%) | 41 (17.7%) | ||
Other | 13 (3.7%) | 7 (2.1%) | 10 (4.3%) | 2 (0.9%) | ||
Transthoracic laterality, n (%) | < 0.001** | 0.735** | ||||
Left | 293 (83.2%) | 196 (55.2%) | 182 (78.8%) | 179 (77.5%) | ||
Right | 57 (16.2%) | 156 (43.9%) | 48 (20.8%) | 52 (22.5%) | ||
Other | 2 (0.6%) | 3 (0.9%) | 1 (0.4%) | 0 (0.0%) | ||
Two-field dissection, n (%) | 0.093* | 1.000* | ||||
No | 30 (8.5%) | 44 (12.4%) | 7 (3.0%) | 8 (3.5%) | ||
Yes | 322 (91.5%) | 311 (97.6%) | 224 (97.0%) | 223 (96.5%) | ||
Three-field dissection, n (%) | < 0.001** | 1.000** | ||||
No | 349 (99.1%) | 316 (89.0%) | 228 (98.7%) | 227 (98.3%) | ||
Yes | 3 (0.9%) | 39 (11.0%) | 3 (1.3%) | 4 (1.7%) | ||
Tumor location, n (%) | 0.647* | 0.776* | ||||
Upper | 31 (8.8%) | 36 (10.1%) | 14 (6.1%) | 12 (5.2%) | ||
Middle | 123 (34.9%) | 131 (36.9%) | 76 (32.9%) | 83 (35.9%) | ||
Lower | 198 (56.3%) | 188 (53.0%) | 141 (61.0%) | 136 (58.9%) | ||
Age (year), n (%) | 0.312* | 0.453* | ||||
≤ 60 | 196 (55.7%) | 211 (59.4%) | 134 (58.0%) | 126 (54.5%) | ||
> 60 | 156 (44.3%) | 144 (40.6%) | 97 (42.0%) | 105 (45.5%) | ||
Median (interquartile range) | 59 (14) | 59 (12) | 0.972*** | 59 (15) | 60 (12) | 0.082*** |
Tumor length (cm) | 0.013** | 0.705* | ||||
≤ 3 | 192 (55.2%) | 162 (45.8%) | 107 (46.9%) | 112 (48.7%) | ||
> 3 | 156 (44.8%) | 192 (54.2%) | 121 (53.1%) | 118 (51.3%) | ||
Median (interquartile range) | 3.0 (2.0) | 3.5 (2.5) | 0.001*** | 3.5 (2.0) | 3.5 (2.5) | 0.776*** |